Related Experiment Video
Updated: Jun 12, 2026
Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
Glutamatergic excitation and GABA release from a transplantable cell line
Jana Mejía-Toiber1, José Abraham Márquez-Ramos, Mauricio Díaz-Muñoz
1Departamento de Neurobiología Conductual y Cognitiva, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Querétaro, México.
Abstract:
The cell line M213-2O CL-4 was derived from cell line M213-2O and further modified to express human glutamate decarboxylase (hGAD-67), the enzyme that synthesizes GABA. Brain transplants of this cell line in animal models of epilepsy have been shown to modulate seizures. However, the mechanisms that underlie such actions are unknown. The purpose of the present study was to characterize this cell line and its responsiveness to several depolarizing conditions, in order to better understand how these cells exert their effects. Intracellular GABA levels were 34-fold higher and GAD activity was 16-fold higher in clone M213-2O CL-4 than in M213-2O. Both cell lines could take up [³H]GABA in vitro, and this uptake was prevented by nipecotic acid. By combining GABA release measurements and calcium imaging in vitro, we found that high extracellular K(+), zero Mg(2+), or glutamate activated M213-2O CL-4 cells and resulted in GABA release. The response to glutamate appeared to be mediated by AMPA/NMDA-like receptors. High KCl-induced GABA release was prevented when a Ca(2+)-free Krebs solution was used, suggesting an exocytotic-like mechanism. These results indicate that the cell line M213-2O CL-4 synthesizes, releases, and takes up GABA in vitro, and can be activated by depolarizing stimuli.
Insights
The M213-2O CL-4 cell line synthesizes and releases GABA, an inhibitory neurotransmitter. This cell line responds to stimuli like high potassium and glutamate, suggesting potential therapeutic applications for epilepsy.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- The M213-2O CL-4 cell line, engineered to express human glutamate decarboxylase (hGAD-67), is derived from M213-2O.
- Previous studies demonstrated its potential in modulating seizures in animal models of epilepsy via brain transplants.
- The precise mechanisms underlying its therapeutic effects remain largely uncharacterized.
Purpose of the Study:
- To comprehensively characterize the M213-2O CL-4 cell line.
- To investigate its responsiveness to various depolarizing conditions.
- To elucidate the mechanisms by which this cell line exerts its effects in neurological conditions.
Main Methods:
- Quantification of intracellular GABA levels and glutamate decarboxylase (GAD) activity.
- In vitro assessment of [³H]GABA uptake, inhibited by nipecotic acid.
- Simultaneous measurement of GABA release and calcium imaging in response to stimuli.
- Investigation of stimulus-induced GABA release under different ionic conditions (high K+, zero Mg2+, Ca2+-free Krebs solution).
Main Results:
- M213-2O CL-4 cells exhibited significantly higher intracellular GABA levels (34-fold) and GAD activity (16-fold) compared to M213-2O cells.
- Both cell lines demonstrated [³H]GABA uptake, sensitive to nipecotic acid.
- High extracellular K+, zero Mg2+, and glutamate activated M213-2O CL-4 cells, leading to GABA release.
- Glutamate-induced GABA release involved AMPA/NMDA-like receptors.
- KCl-induced GABA release was calcium-dependent, suggesting an exocytotic mechanism.
Conclusions:
- The M213-2O CL-4 cell line is capable of synthesizing, releasing, and taking up GABA in vitro.
- Depolarizing stimuli, including glutamate, effectively activate this cell line and trigger GABA release.
- These findings provide a foundation for understanding the cell line's therapeutic potential in epilepsy and other neurological disorders.
More Related Videos
05:00Transplantation of Human Stem Cell-Derived GABAergic Neurons into the Early Postnatal Mouse Hippocampus to Mitigate Neurodevelopmental Disorders
Published on: November 11, 2022
07:16Organotypic Cultures of Adult Human Cortex as an Ex vivo Model for Human Stem Cell Transplantation and Validation
Published on: December 9, 2022